Bharucha AE, Dorn SD, Lembo A, et al
In the STEP 1 trial, approximately 3840% of total weight lost during semaglutide treatment came from lean mass
Frontiers in pharmacology, 10, p.439144
One of these studies tGSH and tGSH:GSSG were significantly lower (by 10.7% and 14.9% respectively) in children with autism who were heterozygous or homozygous for the delta aminolevulinic acid dehydratase (ALAD) 177 GC mutation, whereas there was no difference in GSSG [50]
Acknowledgements This work was supported by grant BK20140049 from the Jiangsu Province Funds for Distinguished Young Scientists, BK20161082 from the Natural Science Foundation of Jiangsu Province and from the National Natural Science Foundation of China(NOs 81274150, 81403092, 81573964)